Researchers to test whether young blood plasma can treat Alzheimer's

08/21/2014 | New Scientist · Gizmodo

A clinical trial will study the effect of blood plasma transfusions from people younger than 30 on patients with mild to moderate Alzheimer's disease. The study will start in October at the Stanford University School of Medicine. A protein in blood plasma called growth differentiation factor 11, or GDF11, declines with age, and it has been linked with improved brain function in animal studies.

View Full Article in:

New Scientist · Gizmodo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA